Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene

  • Peter Mudry1Email authorView ORCID ID profile,
  • Ondrej Slaby2,
  • Jakub Neradil3, 1, 7,
  • Jana Soukalova4,
  • Kristyna Melicharkova1, 7,
  • Ondrej Rohleder1,
  • Marta Jezova5,
  • Anna Seehofnerova6,
  • Elleni Michu2,
  • Renata Veselska3, 1, 7 and
  • Jaroslav Sterba1, 7
BMC Cancer201717:119

https://doi.org/10.1186/s12885-017-3115-x

Received: 2 August 2016

Accepted: 4 February 2017

Published: 10 February 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
2 Aug 2016 Submitted Original manuscript
29 Aug 2016 Reviewed Reviewer Report - Wajd Al-Holou
17 Sep 2016 Reviewed Reviewer Report - Kallesh Danappa Jayappa
26 Oct 2016 Author responded Author comments - Peter Mudry
Resubmission - Version 2
26 Oct 2016 Submitted Manuscript version 2
27 Nov 2016 Reviewed Reviewer Report - Kallesh Danappa Jayappa
28 Nov 2016 Reviewed Reviewer Report - Wajd Al-Holou
10 Jan 2017 Author responded Author comments - Peter Mudry
Resubmission - Version 3
10 Jan 2017 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
23 Jan 2017 Author responded Author comments - Peter Mudry
Resubmission - Version 5
23 Jan 2017 Submitted Manuscript version 5
30 Jan 2017 Author responded Author comments - Peter Mudry
Resubmission - Version 6
30 Jan 2017 Submitted Manuscript version 6
Publishing
4 Feb 2017 Editorially accepted
10 Feb 2017 Article published 10.1186/s12885-017-3115-x

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Pediatric Oncology, University Hospital Brno and School of Medicine, Masaryk University
(2)
Central European Institute of Technology, Masaryk University
(3)
Laboratory of Tumor Biology, Department of Experimental Biology, School of Science, Masaryk University
(4)
Division of Medical Genetics, Department of Biology, University Hospital Brno and School of Medicine, Masaryk University
(5)
Department of Pathology, University Hospital Brno and School of Medicine, Masaryk University
(6)
Department of Pediatric Radiology, University Hospital Brno and School of Medicine, Masaryk University
(7)
International Clinical Research Center, St. Anne’s University Hospital Brno

Advertisement